Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-21-057117

Director sold 755 shares at $49.89 ($37,667)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Salter Malcolm Director 2021-09-17 Sale −755 $49.89 $37,667 12,917 D
Open-market sales · 755 sh · avg $49.89 · $37,667
Loading xslF345X03/doc4.xml…